Providing Cancer Care Closer to Home for Patients With Multiple Myeloma
A Natural Experiment of Providing Cancer Care Closer to Home for Patients With Multiple Myeloma
Sponsor: Washington University School of Medicine
Terminated
Insufficient funding
Other terminated trials from Washington University School of Medicine
- Gynecologic Cancer · Phase NA · Oct 2025
- Extensive-stage Small Cell Lung Cancer · Phase PHASE2 · Aug 2025
- Schizophrenia · Phase PHASE1 · Jan 2025
- Systemic Lidocaine Improves Pain Control After Surgery by Attenuating the Systemic Inflammatory Response to Surgery · Phase PHASE4 · Dec 2024
- Recurrent Rectal Cancer · Phase NA · Nov 2024
See all terminations from Washington University School of Medicine
This NA trial investigates Multiple Myeloma and is currently terminated or withdrawn. Washington University School of Medicine leads this study, which shows 7 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Nov 2024 — Sep 2025 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Sep 2024 — Nov 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jan 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Oct 2023 — Jan 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2023 — Oct 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .